Stay updated on Copanlisib and Nivolumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Copanlisib and Nivolumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision label has been updated from v3.5.3 to v3.5.4, indicating a new page snapshot. This reflects a minor update to the page's version/history.
    Difference
    0.0%
    Check dated 2026-05-15T06:22:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site build update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:45:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:33:30.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added the condition term Malignant lymphoma, large B-cell, diffuse to the study's conditions. Included a new Resources entry linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:23:21.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0. No obvious changes to the study details or user-facing content are visible compared to the previous version.
    Difference
    0.0%
    Check dated 2026-03-19T05:11:05.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:30:51.000Z thumbnail image

Stay in the know with updates to Copanlisib and Nivolumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Copanlisib and Nivolumab in Lymphoma Clinical Trial page.